LONDON (Reuters) - The sexually transmitted disease gonorrhea risks becoming a drug-resistant "superbug" if doctors do not devise new ways of treating it, a leading sexual health expert said.
A widely approved vaccine for meningitis may provide up to 40% protection against gonorrhea in young adults and adolescents, according to new research. This moderate efficacy paired with a targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results